Part D Protected Classes: Manufacturers, Payers Agree On Need For Specifics
Executive Summary
Both levels of review for determining protected classes under Medicare Part D could stand to have more specific guidelines on the selection of participants and on what drug information is to be considered, manufacturers and payers told CMS in comments